ngµç×ÓÓÎÏ·ÐÂÎÅÍøѶ£¨Í¨Ñ¶Ô±Íõ½¿£©È˵ÄÒ»ÉúÖÐÏÕЩÓÐÈý·ÖÖ®Ò»µÄʱ¼äÊÇÔÚ˯ÃßÖжȹýµÄ£¬Ë¯Ã߶ÔÈËÃǵÄÉíÌ念½¡ºÍ¾«Éñ״̬ÖÁ¹ØÖ÷Òª¡£¡£¡£Ë¯ÃßÖçÒ¹½ÚÂÉÊÇָ˯Ãß-ÐѾõģʽÒÔ24Сʱ×óÓÒΪÖÜÆڵı任£¬ÓÖ±»³ÆΪ˯ÃßʱÐÍ£¨chronotype£©£¬¿É·ÖΪÔç˯ÔçÆðµÄ¡°ÇåÔçÐÍ¡±£¨morning-type£©ÓëÍí˯ÍíÆðµÄ¡°Ò¹ÍíÐÍ¡±£¨evening-type£©¡£¡£¡£ËûÃÇÒ²±»ÐÎÏóµØ½Ð×ö¡°°ÙÁéÄñÐÍ¡±£¨¡°larks¡±£©ºÍ¡°Ã¨Í·Ó¥ÐÍ¡±£¨¡°owls¡±£©£¬¶ø´¦ÓÚÖÐÐĵÄÔò±»³ÆΪ¡°ÖÐÐÄÐÍ¡±¡£¡£¡£Í¨³£ÇéÐÎÏ£¬Ôç˯ÔçÆð±»ÒÔΪÊÇ¿µ½¡µÄÉúÑÄÏ°¹ß¡£¡£¡£ÔÚÒÔÍùµÄÑо¿ÖУ¬Ïà±ÈÇåÔçÐÍ£¬Ò¹ÍíÐÍÈËȺµÄÒûʳÓëÔ˶¯Ï°¹ß½Ï²î£¬ÇÒÓëÒÖÓô¡¢·ÊÅÖ¡¢¸ßѪѹ¡¢ÌÇÄò²¡¡¢ÐÄÄÔѪ¹Ü¼²²¡µÈ³£¼ûÂýÐÔ²¡µÄ¹Øϵ¸üΪÇ×½ü¡£¡£¡£¿ÉÊÇ£¬Íí˯ÍíÆðÊÇ·ñÒ²»áÓ°ÏìÈÏÖª¹¦Ð§Ë®Æ½
£¿½áÂÛÉÐÇÒ²»ÇåÎú¡£¡£¡£

¿ËÈÕ£¬ngµç×ÓÓÎÏ·¹«¹²ÎÀÉúѧԺÑо¿ÍŶÓÁªºÏÓ¢¹ú²®Ã÷º²´óѧ¡¢¹ãÖÝÊеÚÊ®¶þÈËÃñÒ½ÔººÍÏã¸Û´óѧµÈÑо¿Ö°Ô±ÅäºÏÔÚ¡¶ÁøÒ¶µ¶¡·×Ó¿¯eClinicalMedicine£¨IF=17.033£©½ÒÏþÌâΪ¡°Chronotype and Cognitive Function: Observational Study and Bidirectional Mendelian Randomization¡±µÄÔ­´´ÐÔÑо¿Ð§¹û£¬½ÓÄɹŰåÊÓ²ìÐÔÑо¿ºÍÃϵ¶ûËæ»ú»¯Á¬ÏµµÄÒªÁ죬Ê×´ÎÉîÈëÕ¹ÏÖÁËÖÐÍíÄêÈË˯ÃßʱÐÍÓëÈÏÖª¹¦Ð§Ë®Æ½µÄÏ໥¹Øϵ¡£¡£¡£

Ñо¿Ö°Ô±Ê×ÏÈ»ùÓÚ¹ãÖÝÉúÎï¿âÐÐÁпªÕ¹ÁËÒ»ÏîÊÓ²ìÐÔÑо¿¡£¡£¡£¹ãÖÝÉúÎï¿âÐÐÁÐÑо¿£¨Guangzhou Biobank Cohort Study, GBCS£©ÊÇ 2003 ÄêÓɹãÖÝÊеÚÊ®¶þÈËÃñÒ½Ôº¡¢Ïã¸Û´óѧºÍÓ¢¹ú²®Ã÷º²´óѧÏàÖú¿ªÕ¹µÄÒ»ÏîÇ°Õ°ÐÔÐÐÁÐÑо¿¡£¡£¡£GBCSÓÚ2003~2008Äê¼äÍê³É»ùÏßÊÓ²ìºÍÌå¸ñ¼ì²é£¬¹²ÄÉÈëÁË30,430Ãû50ËêÒÔÉϵĹãÖݳ£×¡×¡Ãñ¡£¡£¡£Í¨¹ý2008-2012ÄêÍøÂçµÄËæ·ÃÊý¾Ý£¬±¾Ñо¿»ùÓÚ14,582Àý¹ãÖÝÖÐÍíÄêÉçÇøÈËȺ¿ªÕ¹¡£¡£¡£¶à±äÁ¿ÏßÐԻعéÆÊÎöЧ¹ûÏÔʾ£¬Ë¯ÃßÖеãºÍÈÏÖª¹¦Ð§ÆÀ·Ö³ÊÕýÏà¹Ø£¬¼´½ÏÍíµÄ˯ÃßÖеãÓë½Ï¸ßµÄÈÏ֪ˮƽÏà¹Ø¡£¡£¡£ÔÚµ÷½âÁËÐÔ±ð¡¢ÄêËê¡¢Éç»á¾­¼Ã״̬¡¢ÉíÌåÖÊÁ¿Ö¸Êý¡¢ÉúÑÄ·½Ê½¡¢¼²²¡Ê·µÈ»ìÔÓÒòËØÒÔºóÏà¹Ø¹ØϵÒÀÈ»±£´æ (MMSE: ¦Â=0.14; 95% ÖÃÐÅÇø¼ä(CI), 0.09-0.19; DWRT: ¦Â=0.07; 95% CI, 0.04-0.11)¡£¡£¡£

È»¶ø£¬¹Å°åµÄÊÓ²ìÐÔÑо¿ÎÞ·¨¾ÙÐÐÒò¹ûÍƶϣ¬¹Ê²»¿É¶Ï¶¨´Ë¹ØÁªµÄÆ«Ïò¡£¡£¡£Ñо¿Ö°Ô±½Ó׎ÓÄÉË«ÏòÃϵ¶ûËæ»ú»¯£¨Bidirectional Mendelian randomization, BMR£©Ì½Ë÷˯ÃßʱÐͺÍÈÏÖª¹¦Ð§ÕâÁ½Õß¼äÏ໥ӰÏìµÄÒò¹û¹Øϵ¡£¡£¡£Ãϵ¶ûËæ»ú»¯£¨MR£©ÊÇÒ»ÖÖʹÓûùÒò±äÒì×÷Ϊ¹¤¾ß±äÁ¿À´ÍƶÏÑо¿ÒòËØ£¨Ë¯ÃßʱÐÍ£©ºÍ¿µ½¡Ï³¡£¨ÈÏÖª¹¦Ð§£©Ö®¼äÒò¹û¹ØϵµÄÒªÁì¡£¡£¡£ÔÚ»ùÓÚ½ü100ÍòÀýÑо¿Ñù±¾µÄMRÆÊÎöÖУ¬Ñо¿Ö°Ô±·¢Ã÷£¬Ë¯ÃßʱÐͶÔÈÏÖª¹¦Ð§Ã»ÓÐÓ°Ï죬¼´Íí˯²¢²»»á½µµÍÈÏÖª¹¦Ð§¡£¡£¡£Ëæºó£¬Ñо¿Ö°Ô±ÒÔÈÏ֪ˮƽµÄÒÅ´«ÇãÏò×÷ΪÑо¿ÒòËØ£¬À´Ì½Ë÷ÈÏ֪ˮƽ¶ÔÖçÒ¹½ÚÂɱíÐ͵ÄÓ°Ï죬Ч¹ûÔÚ¶àÖÖMRÆÊÎöÖоùÏÔʾËæ×ÅÈÏÖª¹¦Ð§ÆÀ·ÖÉý¸ß£¬Ôç˯µÄ¸ÅÂÊÒ²ËæÖ®½µµÍ (UK Biobank: OR=0.88; 95% CI, 0.83-0.93; 23andMe: 0.87; 95% CI, 0.80-0.95)¡£¡£¡£

ͼ1. ±¾Ñо¿Éè¼ÆÓëÖ÷ҪЧ¹û

ÏÖÔÚ£¬Ë¯ÃßʱÐÍÓëÈÏÖª¹¦Ð§Ö®¼äµÄ¹ØϵÔÚ²î±ðµÄÑо¿Öв¢·×ÆçÖ¡£¡£¡£ÀýÈ磬ÒÔÍùÑо¿·¢Ã÷ÔÚ¶ùͯºÍÇàÉÙÄêÖÐÍí˯ÓëÈÏ֪ˮƽ½ÏµÍÓйأ¬¶øÔÚÖÐÍíÄêÈËÖÐÔò·¢Ã÷Íí˯ÓëÈÏ֪ˮƽ½Ï¸ßÓйء£¡£¡£ÕâÖÖЧ¹ûµÄÇø±ðÓпÉÄÜÊÇÓÉÓÚ¶ùͯºÍÇàÉÙÄêÓÐ׎ÏΪÑÏ¿áµÄ×÷Ϣʱ¼äºÍ¸ü¶àµÄ˯ÃßÐèÇó£¬Íí˯¿ÉÔì³É×Ü˯Ãßʱ³¤ïÔÌ­£¬´Ó¶ø¼ä½ÓÓ°ÏìÁËÈÏÖª¹¦Ð§¡£¡£¡£¶øÔÚ±¾Ñо¿ÄÉÈëµÄ¹ãÖÝÉúÎï¿âÐÐÁÐÖУ¬³¬99%µÄ¼ÓÈëÕßΪÒÑÍËÐݵÄÍíÄêÈË£¬Í¨¹ýÏÖʵ˯ÃßÖеãÍƲâµÄʱÐÍÔò·´Ó³ÁËÌåÄÚÕæʵµÄ˯ÃßÆ«ºÃ¡£¡£¡£±ðµÄ£¬Ñо¿½ÓÄÉ»ùÓÚ´óÑù×Ô¼ºÈºÊý¾Ý¿ªÕ¹MRÆÊÎö£¬¿Éɨ³ý¹Å°åÊÓ²ìÐÔÑо¿ÖÐÍùÍùÎÞ·¨×èÖ¹µÄ»ìÔÓÆ«ÒУ¬ÓÐÖúÓÚÆÊÎö˯ÃßʱÐͺÍÈÏÖª¹¦Ð§µÄÏ໥¹Øϵ¡£¡£¡£

×ÜÖ®£¬Õë¶Ô¡°Íí˯¡±ÕâÒ»±»¹«¹²ÆÕ±é¹Ø×¢µÄ˯ÃßÌØÕ÷£¬±¾Ñо¿Ê״δÓÈËȺ²ãÃæºÍ»ùÒò²ãÃæ֤ʵÁËÍí˯²¢²»»áÓ°ÏìÈÏÖª¹¦Ð§£¬Ïà·´µÄ£¬½Ï¸ßµÄÈÏÖª¹¦Ð§Ë®Æ½»áÔöÌíÍí˯µÄ¸ÅÂÊ¡£¡£¡£¹ØÓÚÓС°Íí˯¡±Ï°¹ßµÄÖÐÍíÄêÈ˶øÑÔ£¬ËûÃǿɲ»±Øµ£ÐÄ˯µÃÍí»áµ¼ÖÂÈÏÖª¹¦Ð§Ï½µ¡£¡£¡£Ñо¿Ð§¹ûÒ²ÓÐÖúÓÚ½øÒ»²½Ã÷È·ÈÏÖª¹¦Ð§µÄÓ°ÏìÒòËغÍ˯ÃßʱÐͶԿµ½¡µÄÓ°Ïì¡£¡£¡£

ngµç×ÓÓÎÏ·¹«¹²ÎÀÉúѧԺ²©Ê¿ºóÍõ½¿ºÍ˶ʿÉúÀèÓ°ÈçΪÂÛÎÄÅäºÏµÚÒ»×÷Õߣ¬ÐìÁÕ½ÌÊÚºÍÖ£¼ÒÇ¿½ÌÊÚΪÅäºÏͨѶ×÷Õß¡£¡£¡£ÂÛÎĵÚÒ»µ¥Î»Îªngµç×ÓÓÎÏ·¹«¹²ÎÀÉúѧԺ¡£¡£¡£¸ÃÑо¿Êܹú¼Ò×ÔÈ»¿Æѧ»ù½ð£¨No. 82103930£©£¬¹ã¶«Ê¡×ÔÈ»¿Æѧ»ù½ð£¨No. 2022A1515011546£©µÈÏîÄ¿µÄ×ÊÖú¡£¡£¡£

ÂÛÎÄÁ´½Ó£ºhttps://authors.elsevier.com/sd/article/S2589-5370(22)00443-6